This panel typically includes SSRIs (such as fluoxetine, sertraline, citalopram, escitalopram, paroxetine), SNRIs (venlafaxine, duloxetine), and atypical agents (bupropion, mirtazapine, trazodone). LC-MS/MS identifies and quantifies these compounds, supporting therapeutic monitoring and forensic applications.
This test is used to confirm medication compliance, evaluate suspected overdose, investigate unexpected side effects or drug interactions, and provide medico-legal documentation. Sample type is urine, serum, or plasma depending on the clinical question.